The long-term outcome and prognosis factor of patients with idiopathic inflammatory myopathies based on myositis-specific autoantibodies.
Wei JiangJingli ShiHongxia YangXiaolan TianHanbo YangQingning ChenLining ZhangQing-Lin PengGuochun WangWei JiangPublished in: Arthritis care & research (2022)
Despite favorable overall survival in patients with IIM, the anti-MDA5-positive subgroup had the highest mortality among all the MSA subgroups, highlighting the distinctive prognosis of patients with different MSA. RP-ILD and malignancy are the most common causes of death of IIM patients. This article is protected by copyright. All rights reserved.
Keyphrases
- end stage renal disease
- interstitial lung disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- systemic lupus erythematosus
- prognostic factors
- oxidative stress
- peritoneal dialysis
- cardiovascular events
- risk factors
- clinical trial
- rheumatoid arthritis
- cell proliferation
- coronary artery disease
- randomized controlled trial
- systemic sclerosis
- cell death
- myasthenia gravis
- double blind